Predicting OncoDX recurrence scores with immunohistochemical markers: effect of stromelysin

Recent reports suggest that immunohistochemistry (IHC) markers can be used to give prognostic information in breast cancer that is similar to that contained in the Genomic Health Inc. OncoDX recurrence score (Onco-RS). Our own previous work confirmed that an IHC model based on estrogen receptor (ER)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Applied immunohistochemistry & molecular morphology 2015-01, Vol.23 (1), p.26-30
Hauptverfasser: Bradshaw, Scott H, Pidutti, Dale, Gravel, Denis H, Song, Xinni, Robertson, Susan J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!